Basiswissen Hyposensibilisierung

Weiterführende Literatur

• Hyposensibilisierung auf Wikipedia
• Pfaar O et al (2022) Guideline on allergen immunotherapy in IgE-mediated allergic diseases. Allergol Select 6: 167-232. doi: 10.5414/ALX02331E
• http://www.daab.de/allergien/hyposensibilisierung/

Mit freundlicher Genehmigung von „my-cme/arztCME“, der Online-Fortbildungsakademie für Fachberufe im Gesundheitswesen.

• Bachert C, Lang B (1999) Histamine und Leukotriene bei der allergischen Rhinitis. Allergologie 8: 492-507
• Bergmann RI et al. (1998) Atopic dermatitis in early infancy predicts allergic airway disease at 5 years. Clin Exp Allergy 28: 965-70
• Bolpacic J et al. (2006) Asthmavorstadium bei Patienten mit Rhinitis allergica. Allergologie. 29(7): 261-7
• Bousquet J et al (1998) WHO Position Paper: Allergen immunotherapy. J Allergy Clin Immunol 53, Suppl. 44: 1-42
• Des Roches A et al. (1997) IT with a standardized Der pter extract. SIT prevents the onset of new sensitiations in children. J Allergy Clin Immunol 99: 450-3
• Durham SR, Kay AB (1985) Eosinophils, bronchial hyperreactivity and late phase asthmatic reaction. Clin Allergy 15: 411-8
• Greisner WA et al. (1998) Co-existence of asthma and allergic rhinitis: A 23-year follow-up study of college students. Allergy Asthma Proc 19: 185-8
• Gronberg H et al. (1993) Early and late nasal symptom response to allergen challenge. The effect of pretreatment with a glucocorticoid spray. Allergy 48: 87-93
• Jacobsen L et al. (1996) IT as a preventive treatment. J Allergy Clin Immunol 97: 232-7
• Kroegel C et al. (1999) Immunologische und molekulare Aspekte des Atemwegsremodelings beim Asthma bronchiale. Allergologie 10: 589-97
• Leitlinie zur Diagnostik und Therapie von Asthma (Hrsg: Deutsche Atemwegsliga e.V. und Deutsche Gesellschaft für Pneumologie, Thieme Verlag, ISBN 3-13-133861-X)
• Maly FE et al. (1997) Mononuclear blood cell suffidoleucotriene generation in the presence of interleukin-3 and whole blood histamine release in honey bee and yellow jacket venom allergy. J Invest Allergol Clin Immunol 7: 217-24
• Martinez FD et al. (1995) Asthma and wheezing in the first six years of life. N Engl J Med 332: 133-8
• Möller C et al. (2002) Pollenimmunotherapy reduces the development of asthma in children with seasonal rhonconjunctivitis (THe PAT-Study). J Allergy Clin Immunol 109: 251-6
• Müller U, Mosbech H (1993) Position paper: Immunotherapy with Hymenoptera venoms. Allergy 48: 37-46
• Nicolai T et al. (2003) Urban traffic and pollutant exposure related to respiratory outcomes and atopy in a large sample of children. Eur Respir J 21(6): 956-63
• Numata T. et al. (1999) Pathophysiological features of the nasal mucosa in patients with idiopathic rhinitis compared to allergic rhinitis. Int Arch Allergy Immunol 119: 304-13
• Ring J, Messmer K (1997) Incidence and severity of anaphylactoid reactions to colloid volume substitutes. Lancet 1: 466-8
• Roberts G et al. (2006) Die Gräserpollen-Immuntherapie als wirksame therapeutische Option bei Kindern mit saisonalem allergischem Asthma Bronchiale. J Allergy Clin Immunol 117: 238-263
• Sears MR (1998) Evolution of asthma through childhood. Clin Exp Allergy 28, Suppl 5: 82-9
• Settipane RJ et al. (1994), Long-term risk factors for developing asthma and allergic rhinitis. Allergy Asthma Proc 15: 21-5
• Sigurs N et al. (1995) Asthma and immunoglobulin antibodies after respiratory syncytial virus bronchiolitis. Pediatrics 95: 500-5
• Spry CFJ (1988) Eosinophils. A comprehensive review and guide to the scientific and medical literature. Oxford: Oxford University Press
• Strachan DP et al. (1997) Worldwide variations in prevalence of symptoms of allergic rhinoconjunctivitis in children: The international Study of Asthma and Allergies in Childhood (ISAAC). Pediatr Allergy Immunol 8: 161-76
• Straumann F et al. (1999) FEIA-Inhibition für die Indikationsstellung zur Hyposensibilisierung bei Doppelsenseibilisierung auf Bienen- und Wespengift. Allergologie, Suppl 2: 65
• von Mutius E et al. (1994) Prevalence of asthma and atopy in two areas of West and East Germany. Am J Respir Crit Care Med 149: 358-64
• Wang H et al. (2006) Doppelblinde, placebokontrollierte Studie zur Immuntherapie gegen Hausstaubmilben bei Asthmapatienten in China. Allergy 61: 191-197
• Weiland (1999), Eur Resp J 14: 862
• Weiss ST (1998) Environmental risk factors in childhood asthma. Clin Exp Allergy 28, Suppl 5: 29-34
• Yuninger JW et al. (1992) A community based study on the epidemiology of asthma. Am Rev Resp Dis 146: 888-94
• Bagnasco M et al. (1997) Absorption and distribution kinetics of the major Parietaria judaica allergen administered by noninjectable routes in healthy human beings. J Allergy Clin Immunol 100: 122-9
• Bhattacharyya SP et al. (1998) Activated T lymphocytes induce degranulation and cytokine production by human mast cells following cell-to-cell contact. J Leukoc Biol 63: 337-341
• Bitter-Suermann D (1988) The anaphylatoxins. In: Rother K, Till G (eds.) The complement system. Berlin, Heidelberg, New York: Springer, 367-395
• Burmester GP, Pezzuto A (1998) Taschenatlas der Immunologie. Stuttgart: Thieme
• Coombs RRA, Gell PGH (1963) The classification of allergic reactions underlying disease. In: Clinical aspects of immunology. Philadelphia: Davis, 317
• Ferrer M et al. (1996) Antigen-specific sulphidoleukotrien production and histaminerelease in pollinotic patients. J Invest Allergol Clin Immunol 6: 271-7
• Foreman I (1987) Substance P and calcitonin gene-related peptide: Effects on mast cells in human skin. Int Arch Allergy Appl Immunol 82: 366-71
• Franken HH et al. (1994) Lack of reproducibility of a single negative sting challenge response in the assessment of anaphylactic risk in patients with suspected yellow jacket hypersensitivity. J Allergy Clin Immunol 93: 431-6
• Galli SJ, Costa JJ (1995) Mast-cell-leukocyte cytokine cascades in allergic inflammation. Allergy 50: 851-62
• Greaves MW, Wall PD (1996) Pathophysiology of itching. Lancet 348: 938-40
• Holgate ST, Kapp A (1993) Allergy. London : Gower Medical Publishing
• Johannson SGO, Bennich HH (1982) The clinical impact of the discovery of IgE. Ann Allergy 48: 325-30
• Kapp A et al. (1985) Involvement of complement in psoriasis and atopic dermatitis – Measurement of C3a and C5a, C3, C4 and C1 inactivator. Arch Dermatol Res 277: 359-61
• Kleine-Tebbe J et al. (2006) Die spezifische Immuntherapie (Hyposensibilisierung) bei IgE-vermittelten allergischen Erkrankungen. Leitlinie der DGAKI, ÄDA und GPA. Allergo J 15: 56-74
• Kleinhans D, Zöllner I (2000) Therapiestudien zur sublingualen Immuntherapie mit Allergenen. Allergologie 7: 349-53
• Malling H-J, Weeke B (1993) Immunotherapy. Position paper of the European Academy of Allergy and Clinical Immunology. Allergy 48: 9-35
• Massey WA (1993) Pathogenesis and pharmacologic modulation of the cutaneous late-phase reaction. Ann Allergy 71: 578-84
• Moingeon P et al. (2006) Immune mechanisms of allergen-specific sublingual immunotherapy, Review article. Allergy 61: 151-165
• Norman PS, Lichtenstein LM (1978) The chemical and immunologic specificity of immunotherapy. J Allergy Clin Immunol 61: 370-7
• Pearce FL (1991) Biological effects of histamine: An overview. Agents Actions 33: 4-7
• Ring J (2004) Angewandte Allergologie. 3. Aufl, Urban & Vogel Verlag, München
• White M (1999) Mediators of inflammation and the inflammatory process. J Allergy Clin Immunol 103: 378-81

Aktuelles aus der Themenwelt

Zum Blog »